«
Logout
|
Web Universe
|
Contact Us
|
About Ebixa
Key publications
For your patients
Prescribing information
Ebixa is very well tolerated
Ebixa is a very well tolerated and safe treatment for moderate to severe AD, with a side-effect level similar to placebo
Ebixa - Efficacy in Alzheimer's disease
Ebixa is an efficacious treatment for moderate to severe Alzheimer’s disease
Ebixa® - The only treatment approved for moderate to severe Alzheimer's Disease
Want to know more about Ebixa?
Ebixa is a specific, uncompetitive NMDA-receptor antagonist, and has a novel mechanism of action for the treatment of patients with moderate to severe Alzheimer’s Disease.
Prescribing information
The Prescribing Information outlines the indications of the product, as well as specifics such as dosage, contra-indications, pregnancy and lactation, precautions, drug interactions, adverse events and overdoses.